Background-Nitrite can be converted to nitric oxide (NO) by a number of different biochemical pathways. In newborn lambs, an aerosol of inhaled nitrite has been found to reduce pulmonary blood pressure, possibly acting via conversion to NO by reaction with intraerythrocytic deoxyhemoglobin. If so, the vasodilating effects of nitrite would be attenuated by free hemoglobin in plasma that would rapidly scavenge NO. Methods and Results-Pulmonary vascular pressures and resistances to flow were measured in anesthetized newborn lambs. Plasma hemoglobin concentrations were then elevated, resulting in marked pulmonary hypertension. This effect was attenuated if infused hemoglobin was first oxidized to methemoglobin, which does not scavenge NO. These results further implicate NO as a tonic pulmonary vasodilator. Next, while free hemoglobin continued to be infused, the lambs were given inhaled NO gas (20 ppm), inhaled sodium nitrite aerosol (0.87 mol/L), or an intravascular nitrite infusion (3 mg/h bolus, 5 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 infusion). Inhaled NO and inhaled nitrite aerosol both resulted in pulmonary vasodilation. Intravascular infusion of nitrite, however, did not. Increases in exhaled NO gas were observed in lambs while breathing the nitrite aerosol (Ϸ20 ppb NO) but not during intravascular infusion of nitrite. Conclusions-We conclude that the pulmonary vasodilating effect of inhaled nitrite results from its conversion to NO in airway and parenchymal lung tissue and is not dependent on reactions with deoxyhemoglobin in the pulmonary circulation. Inhaled nitrite aerosol remains a promising candidate to reduce pulmonary hypertension in clinical application. (Circulation. 2011;123:605-612.)
nanomolar concentrations, is derived from the diet and is a byproduct of nitric oxide (NO) metabolism. 1, 2 Nitrite is converted into biologically relevant concentrations of NO by a number of biochemical pathways (see the review by Lundberg et al 3 ) . The production of NO from the reaction between nitrite and deoxyhemoglobin has received special attention because of its potential for regulating blood flow in hypoxic tissues: NO 2 Ϫ ϩDeoxyHbϩH ϩ 3 MetHbϩNOϩOH (reaction 1). This reaction would be promoted in acidic hypoxic/ischemic regions where the deoxy form of hemoglobin prevails, providing local NO production and tending to match O 2 supply with O 2 requirements. Evidence supporting a role for reaction 1 includes the observation that nitrite infusion to the brachial artery decreases forearm vascular resistance 4, 5 and that inhaled nitrite reduces pulmonary hypertension in hypoxic newborn lambs. 6 Despite these studies, attempts to measure vasoactive concentrations of NO generated by reaction 1 have been unsuccessful, [7] [8] [9] possibly because the rate of NO production by reaction 1 appears to be at least 6 orders of magnitude slower than the rate at which NO would be scavenged by adjacent hemoglobin molecules in the red blood cell.
Clinical Perspective on p 612
A major pathway of NO inactivation within erythrocytes is its reactions with both oxyhemoglobin and deoxyhemoglobin. Either reaction is so rapid that only immeasurably small concentrations of NO can persist for more than milliseconds in the presence of excess hemoglobin. 10 Therefore, when hemoglobin is circulating freely in plasma, it can be predicted to be a highly effective scavenger of NO. In fact, the increased incidence of pulmonary hypertension in patients with hemolytic disorders has been ascribed to depletion of NO by reaction with plasma hemoglobin, 11 although this idea is not without controversy. 12, 13 Nebulized inhaled nitrite has been shown to reduce pulmonary hypertension and to increase exhaled NO in hypoxic newborn lambs. 6 The pulmonary resistance vessels are arterioles and precapillary sphincters that are in contact with both the bloodstream and the alveoli. 14 This anatomic arrangement suggests that inhaled nitrite may cause pulmonary vasodilation by entering the blood at the point of the resistance vessels where it could be converted to NO by reaction 1. Alternatively, nitrite may be converted to NO by other reactions within the airways and adjacent tissues, resulting in vasodilation by a bloodindependent mechanism. We hypothesized that scavenging NO in the blood brought about by infusing hemolyzed blood into the circulation would reveal a blood-independent mechanism for pulmonary vasodilation after nitrite inhalation. To test this hypothesis, we measured the effects of infusion of hemolyzed red cells followed by nitrite infusion, nitrite inhalation, or NO gas inhalation on pulmonary and systemic arterial vascular resistances in newborn lambs.
Methods

Surgical Instrumentation
Procedures involving animals were preapproved by the Loma Linda University Institutional Animal Care and Use Committee. Under general anesthesia, 10-to 20-day-old lambs were surgically instrumented with arterial and venous catheters including a Swan-Ganz catheter in and a transonic blood flow probe on the main pulmonary artery. After surgery, anesthesia was maintained with intravenous ketamine (1 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ) and vecuronium (0.1 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ). See the online-only Data Supplement for details.
Study Protocol
After baseline measurements, plasma hemoglobin concentrations were elevated by infusion of a loading bolus of hemolysate split 1:2 between the pulmonary artery and aorta, followed by a continuous intravenous infusion. After 90 minutes of hemolysate infusion, the lambs were given 1 of 3 treatments: inhaled NO gas (iNO) with 20 ppm (Ikaria, Clinton, NJ) introduced into the inspiratory limb of the ventilator circuit, inhalation of an aerosol produced from a 0.87 mol/L sodium nitrite solution via jet nebulizer (DeVilbiss, Healthcare, Somerset, PA) as previously described, 6 or intravenous sodium nitrite to produce plasma nitrite concentrations of Ϸ100 mol/L.
Vascular Resistances
Cardiac output and systemic arterial pressure, central venous pressure, and pulmonary artery pressure (PAP) were recorded continuously at 200 Hz (Powerlab 16 and Chart version 5.2, ADInstruments, Colorado Springs, CO). Systemic vascular resistance and pulmonary vascular resistance (PVR) were calculated as described in the online-only Data Supplement.
Hemolyzed Blood Preparation
Hemolyzed blood was prepared from heparinized adult sheep blood by 3 cycles of freeze-thawing. The hemolysate was centrifuged for 10 minutes at 5000 rpm at 4°C to remove any unlysed cells. Hemolyzed methemoglobin was prepared by first exposing oxygenated whole blood to NO gas, followed by multiple washes to remove nitrite, and then freeze-thaw cycling.
Analytic Methodology
Previously described methods were used to measure exhaled NO, 6 arterial blood gases, and for hemoximetry, 15 as well as plasma hemoglobin concentrations, 16 nitrite, 15 and L-arginine concentrations 17 (see the online-only Data Supplement).
Vessel Contractility Studies
Fourth-or fifth-order pulmonary arterial rings were studied by wire myography as previously described 18 (see the online-only Data Supplement). One vessel bath was equipped with an amperometric NO probe (ISO-NOP, Apollo 4000, World Precision Instruments, Sarasota, FL) for monitoring NO concentrations. The EC 50 for NO vasodilating the arteries after 10 mol/L 5-hydroxy-tryptamine vasoconstriction was calculated by fitting the data to the Gaddum/ Schild EC 50 equation with the use of Prism version 5.0 (Graphpad Software, La Jolla, CA).
Statistical Analysis
Average values are presented as meanϮSEM. Changes in measured parameters over time were determined by 1-way ANOVA with repeated measures to assess significant changes from baseline and by 2-way ANOVA with repeated measures to assess significant differences between study groups. If the overall 1-or 2-way ANOVA indicated statistical significance, Bonferroni posthoc analysis was performed to identify significant differences at specific time points. Statistical analyses were carried out with Prism 5.0 (Graphpad Software Inc) with significance accepted at PϽ0.05.
Results
Hemolysis Causes Pulmonary Hypertension
Hemolysate (resulting in plasma hemoglobin concentration Ϸ100 mol/L, heme basis; Figure 1A ) was infused and the cardiovascular changes were noted, as shown in Figure 2 . Mean PAP and PVR increased by 48% to 71% to reach nearly steady state with little or no effect on systemic pressure or vascular resistance. These changes were absent or markedly attenuated if the hemoglobin in the infused hemolysate was first oxidized to methemoglobin (Fe 3ϩ state). This demonstrates that hemolysis results in selective pulmonary hypertension and suggests that the mechanism involves the scavenging of NO by plasma Fe 2ϩ -hemoglobin because methemoglobin, which does not scavenge NO, elicited only a small hypertensive response ( Figure 2 ) to hemolysate infusion. To further confirm that the selective pulmonary vasoconstrictive effects of hemolysate were due to hemoglobin and not some other constituent of hemolyzed blood, purified hemoglobin (Sigma Aldrich, St Louis, MO) was infused into 2 additional lambs with comparable selective increases in PAP and PVR noted (see Figure I in the online-only Data Supplement).
Effect of Hemolysis on Plasma L-Arginine
In addition to NO scavenging by plasma hemoglobin, the vasoconstrictive effects of hemolyzed blood could also be caused by depletion of plasma L-arginine resulting from the release of intraerythrocytic arginase. 19 To assess this possibility, we measured L-arginine concentrations in the plasma of the lambs ( Figure 1B ). Plasma L-arginine concentrations decreased from baseline levels within 60 minutes after initiation of hemolysate infusion (from baseline of 127Ϯ11 to 93Ϯ7 mol/L at 60 minutes).
Effect of iNO or Intravenous or Inhaled Nitrite on PVR
Ninety minutes after beginning the infusion of hemolyzed blood, the lambs were treated for another 90 minutes with iNO (nϭ5), inhaled nitrite aerosol (nϭ6), or intravenous nitrite (nϭ6). Both iNO and inhaled nitrite led to a significant decrease in PAP (26% to 31%) and PVR (28% to 34%; Figure  3 ). The finding that iNO could effectively diminish hemolysis-induced pulmonary hypertension was in accor-dance with the established selective vasodilating effects of iNO in the lungs. 20 Likewise, the observation that inhaled nitrite aerosol was an effective pulmonary vasodilator was also consistent with previous work 6 but is contrary to the idea that the underlying mechanism involves reaction 1 because this would require the movement of NO from the erythrocyte through the plasma where it would be scavenged by plasma hemoglobin. That this indeed happens is demonstrated by the Mean PAP (A) and PVR (B) increased significantly with respect to the baseline period and remained elevated for at least 90 minutes in response to unoxidized (Fe 2ϩ ) hemolysate (*PϽ0.01, 1-way ANOVA). In contrast, oxidized (Fe 3ϩ ) hemolysate infusion had no effect on PAP and increased PVR with respect to baseline from 30 to 90 minutes after initiation of the infusion. Both PAP and PVR were significantly elevated after unoxidized hemolysate compared with oxidized hemolysate infusion (PϽ0.01, 2-way ANOVA). Systemic arterial pressures (C) and vascular resistances (D) were not affected by infusion of either unoxidized or oxidized hemolysate. 
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observation that the intravenous infusion of nitrite had minimal effect on PVR. This combination of results provides strong evidence that reaction 1 does not mediate the vasodilating effects of inhaled nitrite aerosol. Consistent with previous reports, 6 inhalation of nitrite aerosol resulted in a significant increase in exhaled NO ( Figure 4A) . In contrast, the intravenous infusion of nitrite did not increase exhaled NO. These differing responses to inhaled and intravenous nitrite cannot be explained by differences between circulating nitrite concentrations, which were at least as high in the lambs that received intravenous nitrite as in those that received inhaled nitrite ( Figure 4B ). The data indicate that a mechanism exists for the conversion of nitrite to NO within the airway and lung tissues, independently of the blood, with subsequent effects of NO on pulmonary resistance vessels.
One possible blood-independent mechanism for the conversion of nitrite to NO in the airways and alveoli is the nonenzymatic chemical disproportionation of nitrite. This reaction, first proposed to contribute significantly to gastric NO concentrations 21 and later demonstrated to occur in ischemic tissues, 22 involves the acidification of nitrite to produce nitrous acid (HNO 2 ), NO 2 Ϫ ϩHϩ7HNO 2 (reaction 2), which then rapidly decomposes via complex chemical reactions to produce NO and other nitrogen oxides. 23 Reaction 2 is pH-dependent with a pK a of Ϸ3.3. Although this is well below the pH of the nitrite solution nebulized in the current experiments (pH 7.0), we reasoned that, given the high concentration of nitrite in the aerosolized solution (0.87 mol/L), disproportionation of even a very small fraction of the nitrite would result in the elevations in exhaled NO concentrations observed in these studies. To test this possibility, the newborn lamb was replaced with a test "lung," a 500-mL neoprene balloon (Ventlab, Mocksville, NC), that was mechanically ventilated with room air using the same ventilator, air flow, and nebulization rates as those used for the lambs. Nitrite solutions identical to those used in the lamb studies were prepared in PBS of varying pH (11.0, 8.5, 7.0, or 4.5) and then nebulized one at a time into the test lung while NO concentrations in the exhaled gas were measured. As shown in Figure 5 , inhaled nitrite resulted in measurable increases in exhaled NO from the balloon, an effect that was inversely proportional to the pH of the nitrite solution. At pH 7.0, increases in NO exhaled from the balloon were similar in magnitude to the current and previously reported lamb experiments. 6 These data show that increases in exhaled NO in lambs during inhalation of nitrite aerosol can be accounted for by nitrite disproportionation in the ventilator circuit and pulmonary airway gas space.
Sensitivity of Pulmonary Arteries to NO
It is generally accepted that for vasodilating effects, NO concentrations have to rise at least to the 5-to 10-nmol/L level. 24 To determine the response curves in newborn lambs, isolated pulmonary arteries were studied by wire myography. Exposure of precontracted arteries to increasing concentrations of NO in the vessel bath resulted in measurable relaxation of the vascular smooth muscle at concentrations of Ϸ1 nmol/L and higher with an EC 50 of 953Ϯ120 nmol/L ( Figure 6 ), suggesting that NO concentrations in the nanomolar range are needed to produce a significant decrease in PVR.
Discussion
These experiments in the newborn lamb demonstrate that hemolyzed blood induces selective pulmonary vasoconstric- tion mostly as a result of the scavenging of NO by hemoglobin free in plasma. This pulmonary hypertension is effectively reduced by the administration of iNO and nitrite aerosol but not by intravenous nitrite infusion. The data also show that the vasodilating effects of inhaled nitrite aerosol are not mediated by the reaction of nitrite with deoxyhemoglobin in red blood cells. Instead, the experiments suggest that inhaled nitrite aerosol produces vasoactive amounts of NO in the airways, alveoli, and other pulmonary tissues, which then relaxes vascular smooth muscle cells. Much of the NO is likely produced by nonenzymatic disproportionation.
Mechanism and Treatment of Pulmonary Hypertension Caused by Hemolysis
NO reacts with oxyhemoglobin at a nearly diffusion-limited rate, 25 resulting in the conversion of NO to biologically inert nitrate. The diffusion of endothelium-derived NO into the erythrocyte is slowed nearly 1000-fold as a result of an unstirred layer of plasma surrounding the erythrocyte 26 and a cell-free zone of plasma lining the endothelial layer of vessels. 27 Accordingly, in the presence of free hemoglobin in plasma, NO scavenging is accelerated by 2 to 3 orders of magnitude, and the amount of NO from the endothelium available for vasodilation is decreased, even at plasma hemoglobin concentrations in the low-micromolar range. 28 This NO scavenging is thought to cause hypertension associated with hemolysis or after administration of blood substitutes containing cell-free hemoglobin. 29 The present observation that the pulmonary vasoconstricting effects of hemolysate are diminished by first oxidizing the hemoglobin to methemoglobin (Fe 3ϩ ), which does not effectively scavenge NO, further suggests that the vasoconstrictive effects are due mostly to NO scavenging as opposed to the action of other hemolysate components. Similar pulmonary hypertension after infusion of reconstituted hemoglobin in solution without other hemolysate products further supports this conclusion (see the online-only Data Supplement).
Hemolysis also results in the release of erythrocytic arginase into the plasma, 19 which might have limited endothelial NO production. Indeed, hypoargininemia, elevated plasma arginase, and endothelial impairment have been associated with hypertension in hemolytic patients, 30 and in the present experiments, plasma arginine concentrations did decrease measurably, as shown in Figure 1B . The degree of hypoargininemia, however, seems unlikely to have caused pulmonary hypertension because similar decreases of arginine were observed in lambs treated with methemoglobin hemolysate, with no significant associated pulmonary hypertension.
Although systemic vasoconstriction is a hallmark response to millimolar concentrations of intravascular plasma hemoglobin and hemoglobin substitutes, 29 the present studies demonstrate that micromolar concentrations of plasma hemoglobin result in selective pulmonary vasoconstriction. Our observations are consistent with recent results from a murine model of hemolysis-induced pulmonary hypertension 31 and a A B Figure 5 . pH-dependent production of exhaled NO from nebulized nitrite solution in a mechanically ventilated neoprene test lung. Ventilator circuit configuration and airflow and pressure settings were identical to those of the newborn lamb experiments. Four separate aliquots of nitrite solution (0.87 mol/L) solution were prepared in PBS, and pH was subsequently adjusted to 11.1, 8.6, 7.0, or 4.6. A, Representative experiment showing increases in exhaled NO gas at magnitudes inversely proportional to pH during nitrite inhalation. B, Average exhaled NO gas concentrations at the 4 pH levels (nϭ3). Average exhaled NO concentrations from the lambs given inhaled nitrite are shown for comparison, demonstrating comparable levels of exhaled NO from the test lung at pH 7.0. number of clinical associations between pulmonary hypertension and hemolytic conditions such as sickle cell disease, thalassemia, and autoimmune hemolytic anemia (see the review by Morris et al 32 ) , although the true incidence of pulmonary hypertension and its proposed pathogenesis have been debated. 12, 13 The present findings support the idea that the pulmonary vasculature is particularly dependent on tonic vasodilation caused by NO.
iNO potently dilates the pulmonary vasculature but is scavenged by hemoglobin in the blood so rapidly that its systemic effects are minimal. 20 In the case of pulmonary hypertension caused by hemolysis, iNO may have the added benefit of oxidizing cell-free hemoglobin to methemoglobin, thereby reducing the NO scavenging of plasma hemoglobin. This effect of iNO has been demonstrated previously in canine 33 and murine 34 hemolysis models and in sickle cell patients. 35 The rapid reappearance of pulmonary hypertension after discontinuation of iNO in the present studies suggests that the duration of treatment may not have been sufficient to fully oxidize all plasma free hemoglobin. Alternatively, iNO may have inhibited pulmonary endothelial NO synthase activity 36 so that, even after fully oxidizing the plasma free hemoglobin, there was insufficient endogenous NO production to allow pulmonary vasodilation.
Mechanism of Nitrite Reduction to NO and Pulmonary Vasodilation
The previous observation that administration of inhaled nitrite aerosol to newborn lambs resulted in pulmonary vasodilation and exhaled NO and that these effects were enhanced by systemic hypoxia 6 was interpreted as support for the idea that the reaction of nitrite with deoxyhemoglobin produces vasoactive NO. The present study demonstrates in the same animal model, however, that the pulmonary vasodilation and exhaled NO observed during nitrite inhalation are not prevented by the presence of cell-free hemoglobin to scavenge NO in plasma. Furthermore, unlike inhaled nitrite, intravenous nitrite infusion resulted in neither pulmonary vasodilation nor exhaled NO. Together, these observations demonstrate that the mechanism for conversion of inhaled nitrite to NO does not occur in the blood in a newborn lamb model of pulmonary hypertension induced by hemolysis.
During embryonic development, the pulmonary arterial vasculature forms alongside the airways, resulting in the pulmonary resistance vessels being in close proximity to the smaller airways. 37 The closeness is particularly true at the level of the small precapillary arterioles and sphincters, which are juxtaposed directly with the terminal airways without an intervening basal lamina. 14 Functional evidence of the ability of the airway to influence pulmonary vascular tone is demonstrated by the observation that hypoxic pulmonary vasoconstriction is caused by decreases in airway PO 2 more so than decreased PO 2 of the pulmonary arterial circulation. 38 The present experiments with the neoprene test lung demonstrate that measurable amounts of inhaled nitrite can be converted to NO independently of pulmonary tissues. The pH dependence of this reaction is suggestive of disproportionation (reaction 2). The comparable level of exhaled NO in the test lung and lambs at pH 7.0 shows that disproportionation is quantitatively sufficient to explain the source of exhaled NO in the lambs during nitrite inhalation. Whether gas-phase NO concentrations during nitrite inhalation were adequate to cause pulmonary vasodilation is unclear. Dyar et al 39 have reported the ED 50 for iNO to be 39 ppm (Ϸ78 nmol/L in aqueous solution), which does not contradict our doseresponse curve ( Figure 6 ). This gas-phase NO concentration is Ϸ3 orders of magnitude higher than those measured in the exhaled air of the lambs receiving inhaled nitrite in the current study. This discrepancy may indicate that other pathways are also involved in the vasodilating effects of inhaled nitrite, which could be converted to NO inside the walls of the resistance vessels or in their proximity by reacting with a number of metal-containing proteins such as xanthine oxidase, 40 aldehyde oxidase, 41 NO synthase, 42 cytoglobin and neuroglobin, 43 carbonic anhydrase, 44 and cytochrome c 45 ; the reactions of these proteins with nitrite in pulmonary tissue do not appear to have been characterized to date.
It is worth noting that the use of hemolyzed blood in the present experiments confounds assessment of the contribution of the reaction of deoxyhemoglobin and nitrite to the control of pulmonary vascular tone. In previous studies, intravenous nitrite has been reported to produce significant pulmonary vasodilation during hypoxia, but the effects were transient and the nitrite dose was Ϸ5-fold higher than in the present study. 15 In experiments with isolated rat lungs ventilated with hypoxic gas, perfusion with buffer containing 20 mol/L nitrite resulted in vasodilation, but the effect was abolished by the addition of whole blood to the perfusate. 46 Thus, the role of the conversion of nitrite to NO by reaction with deoxyhemoglobin in the regulation of pulmonary vascular tone has yet to be fully characterized at physiological nitrite concentrations.
Clinical Implications
The present study, in agreement with previous work, 6 demonstrates that inhaled nitrite aerosol is an effective treatment for pulmonary hypertension in the newborn lamb. In a clinical setting, the relative simplicity, safety, prolonged action, 6 and cost-effectiveness of handling and administering a nitrite aerosol compared with compressed NO gas may make inhaled nitrite an attractive alternative for many intensive care settings. However, the disproportionation reaction implicated in the present studies would also likely include intermediates such as N 2 O 3 , N 2 O 4 , and NO 2 , 23 all three of which are reactive in biological tissues and may lead to nitrosative and oxidative damage. Although no significant signs of methemoglobin accumulation, deterioration in pulmonary function, or other adverse effects were observed in the present or prior 6 lamb studies, toxicity was not a primary focus and should be studied before clinical application of this treatment.
Conclusions
The present experiments provided nitrite as an aerosol in the inspired air to newborn lambs under normoxic conditions. The inhaled nitrite was converted to vasodilating concentrations of NO and led to distinct increases in plasma nitrite concentrations. However, in contrast to previous experiments
